Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture
- PMID: 2535943
Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture
Abstract
Tumor necrosis factor (TNF), a mediator of the inflammatory response, induces tissue factor and decreases the expression of thrombomodulin (TM) on endothelial cells, thus shifting the hemostatic properties of the endothelium. To determine the mechanism of TM downregulation, bovine aortic endothelial cells in culture were treated with TNF (2 nmol/L) and the fate of TM followed. Both surface expressed TM (antigen and activity), and the total TM pool (measured by radioimmunoassay and activity in detergent extracts) dropped to less than or equal to 20% of control values within 12 hours of TNF treatment. TM was not found in an immunologically recognizable form in the supernatants of treated cultures. Chloroquine (greater than or equal to 100 mumol/L) was able to abrogate the TNF effect on the total TM pool but not the effect on surface-expressed TM activity. We conclude that TNF induces the internalization and subsequent degradation of the TM molecule. None of the components of the protein C anticoagulant pathway, either alone or in combination, prevented the TNF-dependent downregulation of TM antigen.
Similar articles
-
Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor.Blood. 1992 Nov 15;80(10):2556-62. Blood. 1992. PMID: 1330076
-
Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms.Blood. 1991 Feb 1;77(3):542-50. Blood. 1991. PMID: 1846763
-
Differential effect of tumor necrosis factor-alpha on thrombomodulin gene expression by human monocytoid (THP-1) cell versus endothelial cells.Int J Hematol. 1998 Jan;67(1):53-62. doi: 10.1016/s0925-5710(97)00080-7. Int J Hematol. 1998. PMID: 9594445
-
Thrombomodulin, an endothelial anticoagulant; its structure, function and expression.Jpn Circ J. 1992 Feb;56(2):187-91. doi: 10.1253/jcj.56.187. Jpn Circ J. 1992. PMID: 1312651 Review.
-
Microthrombosis in sepsis.Minerva Anestesiol. 2001 Apr;67(4):298-301. Minerva Anestesiol. 2001. PMID: 11376528 Review.
Cited by
-
Hyperbaric oxygen therapy prevents coagulation disorders in an experimental model of multiple organ failure syndrome.Intensive Care Med. 2006 Nov;32(11):1881-8. doi: 10.1007/s00134-006-0367-3. Epub 2006 Sep 15. Intensive Care Med. 2006. PMID: 16977483
-
[Coagulation dysfunction in COVID-19].Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(3):340-346. doi: 10.3785/j.issn.1008-9292.2020.05.02. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 32762158 Free PMC article. Review. Chinese.
-
Anticoagulation Strategies during Extracorporeal Membrane Oxygenation: A Narrative Review.J Clin Med. 2022 Aug 31;11(17):5147. doi: 10.3390/jcm11175147. J Clin Med. 2022. PMID: 36079084 Free PMC article. Review.
-
Pathogenesis of thrombosis in patients with malignancy.Int J Hematol. 2001 Feb;73(2):137-44. doi: 10.1007/BF02981929. Int J Hematol. 2001. PMID: 11372723 Review.
-
Thrombomodulin in intensive care patients.Intensive Care Med. 1995 Aug;21(8):645-50. doi: 10.1007/BF01711542. Intensive Care Med. 1995. Retraction in: Intensive Care Med. 2023 Aug;49(8):1048. doi: 10.1007/s00134-023-07142-4. PMID: 8522668 Retracted.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
